THE ROLE OF BRACHYTHERAPY IN TREATMENT FOR ESOPHAGEAL CANCER
##article.numberofdownloads## 74
##article.numberofviews## 65
PDF (Русский)

Keywords

ESOPHAGEAL CANCER
INTRALUMINAL BRACHYTHERAPY

How to Cite

Tyuryaeva, Y. (2017). THE ROLE OF BRACHYTHERAPY IN TREATMENT FOR ESOPHAGEAL CANCER. Voprosy Onkologii, 63(4), 660–665. https://doi.org/10.37469/0507-3758-2017-63-4-660-665

Abstract

The article is devoted to various aspects of the use of intraluminal brachytherapy (IB) in treatment for esophageal cancer (EC). A critical review of the use of IB as a component of combined radiotherapy/chemoradiotherapy in neoadjuvant treatment regimens, for definitive CRT, as well as in palliative treatment of non-operable tumors of this localization is given. The contradictory data on the effectiveness of brachytherapy with locally distributed, inoperable EC are summarized. A separate section relates to the prospects for incorporating brachytherapy into combined treatment of early esophageal cancer. Carried out analysis testifies to the necessity of standardization of summary and daily doses of irradiation depending on the indications to the IB.
https://doi.org/10.37469/0507-3758-2017-63-4-660-665
##article.numberofdownloads## 74
##article.numberofviews## 65
PDF (Русский)

References

Левченко Е.В., Канаев С.В., Тюряева Е.И., Дворецкий С.Ю., Щербаков А.Г., Комаров И.В., Хандогин Н.В., Иванцов А.О., Шабатуров Л.Ю. Результаты комплексного лечения больных раком грудного отдела пищевода // Вопросы онкологии. - 2016. - Т. 62. - № 2. - С. 302-309.

Bedenne L., Michel P, Bouche О. et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102 // J. Clin. Oncol. - 2007. - Vol. 25. - P. 1160-1168.

Bergquist H., Wenger U., Johnsson E. et al. Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial // Dis Esophagus. - 2005. - Vol. 18. - № 3. - P 131-139.

Bhatt L.,Tirmazy S., Sothi S. Intraluminal high-dose-rate brachytherapy for palliation of dysphagia in cancer of the esophagus: initial experience at a single UK center // Dis Esophagus. - 2013. - Vol. 26. - № 1. - P. 57-60.

Eldeeb H, Reza S., Shmueli U. et al. External beam radiotherapy versus brachytherapy in the management of malignant oesophageal dysphagia: a retrospective study // J. BUON. - 2012. - Vol. 17. - № 3. - P. 508-511.

Fietkau R. Definitive and neoadjuvant radiochemotherapy of squamous cell carcinoma of the oesophagus // Onkol-ogie. - 2004. - Vol. 27. - P. 39-44.

Frobe A, Jones G., Jaksic B. et al. Intraluminal brachy-therapy in the management of squamous carcinoma of the esophagus // Dis Esophagus. - 2009. - Vol. 22. - № 6. - P 513-518.

Gaspar L.E., Nag S., Herskovic A., et al. American Brachy-therapy Society (ABS) consensus guidelines for brachy-therapy of esophageal cancer. Clinical Research Committee, American Brachytherapy Society, Philadelphia, PA // Int. J. Radiat. Oncol. Biol. Phys. - 1997. - Vol. 38. - № 1. - P 127-132.

Gaspar L.E., Qian C., Kocha W.I. A phase I/II study of external beam radiation, brachytherapy and con current chemotherapy in localized cancer of the esophagus (RTOG 92-07): preliminary toxicity report // Int. J. Radiat. Oncol. Biol. Phys. - 1997. - Vol. 37. - № 3. - P. 593-599.

Gaspar L.E., Winter K., Kocha et al. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report // Cancer. - 2000. - Vol. 88. - P. 988-995.

Grazziotin R., Reisner M.L., Rosa A.A. et al. HDR brachy-therapy in advanced esophageal cancer: Analysis of the palliation of dysphagia in 108 patients // J. Clin Oncology. - 2011. - Vol. 29. - № 15. - e14599.

Guedeu F., Mazeron J.-J., Ventura M. Pattern of care brachytherapy in Europe. In:Choices in advanced radiotherapy. Proceeding based on the 12th Conference Optimal use of advanced radiotherapy in multimodality oncology. - Rome, Italy, 2007. - pp. 309-317.

Gwynne S., Hurt C., Evans M. et al. Definitive chemo-radiation for oesophageal cancer- a standard of care in patients with non-metastatic oesophageal cancer // Clin. Oncol. R. Coll. Radiol. - 2011. - Vol. 23. - № 3. - P. 182-188.

Hironaka S., Ohtsu A., Boku N., Muto M. et al. Nonrandomized comparison between definitive chemoradio-therapy and radical surgery in patients with T2-3NanyM0 squamous cell carcinoma of the esophagus // Int. J. Radiat. Oncol. Biol. Phys. - 2003. - Vol. 57. - P 425-433.

Homs M.Y, Steyerberg E.W., Eijkenboom W.M. et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial // Lancet. - 2004. - Vol. 364. - P 1497-1504.

Igaki H., Kato H., Tachimori Y et al. Clinicopathologic characteristics and survival of patients with clinical Stage I squamous cell carcinomas of the thoracic esophagus treated with three-field lymph node dissection // Eur. J. Cardiothorac. Surg. - 2001. - Vol. 20. - P 1089-1094.

Kato H., Udagawa H., Togo A. et al. A phase II trial of chemo-radiotherapy in patients with stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group study (JCOG9708) // Proc. Am. Soc. Clin. Oncol. - 2003. - Vol. 22. - abstr 1147.

Kato H., Sato A., Fukuda H. A Phase II Trial of Chemoradio-therapy for Stage I Esophageal Squamous Cell Carcinoma: Japan Clinical Oncology Group Study (JCOG9708) // Jpn. J. Clin. Oncol. - 2009. - Vol. 39. - № 10. - 638-643.

Kapoor R., Bansal A., Kochhar R. et al. Effectiveness of Two High-dose-rate Intraluminal Brachytherapy Schedules for Symptom Palliation in Carcinoma Esophagus: A Tertiary Care Center Experience // Indian J. Palliat. Care. - 2012. - Vol. 18. - № 1. - P. 34-39.

Kranzfelder M., Schuster T., Geinitz H. et al. Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer // Br. J. Surg. - 2011. - Vol. 98. - P 768-783.

Kurokawa Y, Muto M., Minashi K. et al. A Phase II Trial of Combined Treatment of Endoscopic Mucosal Resection and Chemoradiotherapy for Clinical Stage I Esophageal Carcinoma: Japan Clinical Oncology Group Study JCOG0508 // Jpn. J. Clin. Oncol. - 2009. - Vol. 39. - № 10. - P. 686- 689.

Lee H.K., Vaporciyan A.A., Cox J.D. et al. Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma:correlation with pulmonary dose-volume histogram parameters // Int. J. Radiat. Oncol. Biol. Phys. - 2003. - Vol. 57. - P 1317-1322.

Lordick F., Mariette C., Haustermans K. et al. Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up // Annals of Oncology. - 2016. - Vol. 27 (Supplement 5). - P. v50-v57. - 10.1093/ annonc/mdw329. DOI: 10.1093/annonc/mdw329

Merkow R. P, Bilimoria K.Y, Keswani R. N. et al. Treatment Trends, Risk of Lymph Node Metastasis, and Outcomes for Localized Esophageal Cancer // J. Natl. Cancer Inst. - 2014. - Vol. 106. - dju133.

Minashi K., Ohtsu A., Mera K. et al. Combination of endoscopic mucosal resection and chemoradiotherapy as a nonsurgical treatments for patients with clinical stage I esophageal squamous cell carcinoma // J. Clin. Oncol. - 2007. - Vol. 25 (Suppl 18). - p. 4529.

Minsky B.D., Pajak T.F., Ginsberg R.J. et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combinedmodality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy // J. Clin. Oncol. - 2002. - Vol. 20. - P. 1167-1174.

Muijs C.T., Beukema J.C., Mul V.E. et al. External beam radiotherapy combined with intraluminal brachytherapy in esophageal carcinoma // Radiother. Oncol. - 2012. - Vol. 102. - № 2. - P. 303-308.

Murakami Y, Kenjo M., Uno T. Results of the 1999-2001 Japanese Patterns of Care Study for Patients Receiving Definitive Radiation Therapy without Surgery for Esophageal Cancer // Jpn. J. Clin. Oncol. - 2007. - Vol. 37. - № 7. - P. 493-500.

Murakami Y, Nagata Y, Nishibuchi I. et al. Long-term outcomes of intraluminal brachytherapy in combination with external beam radiotherapy for superficial esophageal cancer // Int. J. Clin. Oncol. - 2012. - Vol. 17. - № 3. - P. 263-271.

Nemoto K., Matsumoto X. Yamakawa M. et al. Treatment of superficial esophageal cancer by external radiation therapy alone: results of a multi-institutional experience // Int. J. Radiat. Oncol. Biol. Phys. - 2000. - Vol. 46. -№ 4. - P 921-925.

Nishio M., Horikawa Y, Morita K. et al.[The usefulness of intracavitary brachytherapy in esophageal cancer] // Gan No Rinsho. - 1988. - Vol. 34(3). - P 261-268.

Nishio M., Sakurai T, Kagami Y et al. [The dose of radiotherapy in esophageal cancer combined with external beams and intracavitary radium brachytherapy] // Gan No Rinsho, 1987. - Vol. 33. - № 3. - P. 242-248.

Noordman B.J., Shapiro J., Spaander M.C. Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and Protocol. http://www.trialregister.nl/ trialreg/admin/rctview.asp?TC=4834 (archived by Webcite at http://www.webcitation.org/6Ze7mn67B).

Polinder S., Homs M.Y, Siersema PD. et al. Cost study of metal stent placement vs single-dose brachytherapy in the palliative treatment of oesophageal cancer // Br. J. Cancer. - 2004. - Vol. 90. - № 11. - P. 2067-2072.

Rowland C.G., Pagliero M. Intracavitary irradiation in palliation of carcinoma of the esophagus and cardia // Lancet. - 1985. - № 2. -P. 981-983.

Sharma V., Mahantshetty U., Dinshaw K.A. et al. Palliation of advanced/recurrent esophageal carcinoma with high-dose-rate brachytherapy // Int. J. Radiat. Oncol. Biol. Phys. - 2002. - Vol. 52. - P. 310-315.

Stahl M., Stuschke M., Lehmann N. et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus // J. Clin. Oncol. - 2005. - Vol. 23. - P. 2310-2317.

Suh Y-G., Lee I. J., Koom W.S. High-dose Versus Stan-dard-dose Radiotherapy with Concurrent Chemotherapy in Stages II-III Esophageal Cancer // Jpn. J. Clin. Oncol. - 2014. - Vol. 44. - № 6. - P. 534-540.

Sur R.K., Levin C.V., Donde B. et al. Prospective Randomized Trial of HDR Brachytherapy as a Sole Modality in Palliation of Advanced Esophageal Carcinoma - An International Atomic Energy Agency Study // Int. J. Ra-diat. Oncol. Biol. Phys. - 2002. - Vol. 53. - P. 127-133.

Takagi I. [Afterloading interstitial brachytherapy combined with external radiation and surgery in the treatment of locally far-advanced lung cancer and esophageal cancer] // Nihon Kyobu Geka Gakkai Zasshi. - 1988. - Vol. 36. - № 10. - P 2200-2212.

Teoh A.Y, Chiu P.W., Yeung W.K. et al. Long-term survival outcomes after definitive chemoradiation versus surgery in patients with resectable squamous carcinoma of the esophagus: results from a randomized controlled trial // Ann. Oncol. - 2013. - Vol. 24. -P 165-171.

The National Comprehensive Cancer Network Guidelines in Oncology. Esophageal cancer. http://www.nccn.org. Accessed March 15, 2013.

Toita T, Ogawa K., Genki A. et al. Concurrent Chemo-radiotherapy for Squamous Cell Carcinoma of Thoracic Esophagus: Feasibility and Outcome of Large Regional Field and High-dose External Beam Boost Irradiation // Jpn. J. Clin. Oncol. - 2001. - Vol. 31. - P. 375-381.

Zhang P, Xie C.Y, Wu SX. Concurrent chemoradiation with paclitaxel and platinum for locally advanced esophageal cancer // Zhonghua Zhong Liu Za Zhi. - 2007. - Vol. 29. - № 10. - P. 773-777.

Zhou G., Chen G., Cui S. et al. External irradiation combined with intracavitary brachytherapy for esophageal cancer // Zhonghua Wai Ke Za Zhi. - 2001. - Vol. 39. - №.12. - P. 925-927.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

© АННМО «Вопросы онкологии», Copyright (c) 2017